Rockwell Medical Inc. announced the extension of its Amended and Restated Product Purchase Agreement with one of the largest dialysis providers in the United States. The agreement, originally dated September 18, 2023, has been extended through December 31, 2026. As part of the extension, product pricing will be increased for the duration of the new term. Further details are available in the Form 8-K filed on January 5, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rockwell Medical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260105304475) on January 05, 2026, and is solely responsible for the information contained therein.
Comments